Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814).
Sims JR, Selzler KJ, Downing AM, Willis BA, Aluise CD, Zimmer J, Bragg S, Andersen S, Ayan-Oshodi M, Liffick E, Eads J, Wessels AM, Monk S, Schumi J, Mullen J.
Sims JR, et al. Among authors: ayan oshodi m.
J Prev Alzheimers Dis. 2017;4(4):247-254. doi: 10.14283/jpad.2017.38.
J Prev Alzheimers Dis. 2017.
PMID: 29181490
Review.